Literature DB >> 307873

Predictors of operative mortality for coronary bypass grafting in patients with ischemic heart disease.

R A Langou, J C Wiles, P N Peduzzi, G Hammond, L S Cohen.   

Abstract

Predictors for operative mortality (OM) were studied in 172 consecutive patients (pts) undergoing coronary artery grafts (CAG) for angina pectoris.Seventy eight pts had Class IV angina; of the 147 patients given propranolol, 41 were gradually withdrawn from propranolol and finally discontinued 24 hours before surgery, and 106 were abruptly withdrawn from propranolol 24 hours before CAG; 20 pts had left main coronary disease; 156 pts had cardiopulmonary bypass (CPB) time shorter than 20 minutes, and 16 pts had a CPB longer than 120 minutes.The operative mortality was 5.2% (9/172) for the entire group. Class IV angina (OM 7%), abrupt propranolol withdrawal (OM 6.6%), left main coronary artery disease (OM 25%), and CPB longer than 120 minutes (OM 50%), all significantly increased OM. These variables were interdependent, however, as many pts belonged to several predictor categories, combinations of predictors were examined, in order to more accurately predict the risk of individual pts. The combination of left main coronary artery disease and CPB longer than 120 minutes; and Class IV angina and CPB longer than 120 minutes were significantly associated with higher operative mortality.We conclude that Class IV angina, abrupt propranolol withdrawal, left main coronary artery disease and prolonged CPB are potent, interdependent predictors of OM in pts undergoing CAG. Consideration of these predictors, alone and in combination, allows effective prediction of OM for CAG in patients with stable angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 307873      PMCID: PMC2595643     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  26 in total

1.  Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgery.

Authors:  D J Coltart; M N Cayen; E B Stinson; R H Goldman; R O Davies; D C Harrison
Journal:  Br Heart J       Date:  1975-12

2.  Aortocoronary saphenous vein bypass. Results in 1,492 patients, with particular reference to patients with complicating features.

Authors:  D A Cooley; J T Dawson; G L Hallman; F M Sandiford; D C Wukasch; E Garcia; R J Hall
Journal:  Ann Thorac Surg       Date:  1973-10       Impact factor: 4.330

3.  Exercise stress testing in evaluation of aortocoronary bypass surgery. Report of 123 patients.

Authors:  A G Bartel; V S Behar; R H Peter; E S Orgain; Y Kong
Journal:  Circulation       Date:  1973-07       Impact factor: 29.690

4.  Results of aortocoronary artery saphenous vein bypass surgery for ischemic heart disease.

Authors:  M Najmi; K Ushiyama; G Blanco; A Adam; B L Segal
Journal:  Am J Cardiol       Date:  1974-01       Impact factor: 2.778

5.  Withdrawal of propranolol and myocardial infarction.

Authors:  R Slome
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

6.  Estimation of left ventricular volume by one-plane cineangiography.

Authors:  D G Greene; R Carlisle; C Grant; I L Bunnell
Journal:  Circulation       Date:  1967-01       Impact factor: 29.690

7.  Propranolol and cardiac surgery.

Authors:  J F Viljoen; F G Estafanous; G A Kellner
Journal:  J Thorac Cardiovasc Surg       Date:  1972-11       Impact factor: 5.209

8.  Coronary artery syndromes after sudden propranolol withdrawal.

Authors:  E L Alderman; D J Coltart; G E Wettach; D C Harrison
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

9.  The nature of treatment selection in coronary artery disease. Experience with medical and surgical treatment of a chronic disease.

Authors:  J F McNeer; C F Starmer; A G Bartel; V S Behar; Y Kong; R H Peter; R A Rosati
Journal:  Circulation       Date:  1974-04       Impact factor: 29.690

10.  The "bad" left ventricle. Results of coronary surgery and effect on late survival.

Authors:  J C Manley; J F King; H J Zeft; W D Johnson
Journal:  J Thorac Cardiovasc Surg       Date:  1976-12       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.